- Home
- / Pharscin
Pharscin
Stock Price
¥14
2024-10-29
Market Capitalization
¥5.7 B
2024-10-29
Revenue
¥802 M
FY, 2025
Pharscin Summary
Company Summary
- Overview
- Pharscin is a company that produces and sells drugs. Its products include tablets, injections, medicines, dry powders, etc. The company offers products for CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular-related diseases.
- Type
- Public
- Status
- Active
- Founded
- 1996
- HQ
- CN | view all locations
- Website
- http://www.pharscin.com
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
1 location detected
Chongqing HQ
China
Yubei District
Pharscin Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥209.9M
- Gross profit (Q1, 2026)
- ¥125.0M
- Net income (Q1, 2026)
- ¥28.9M
- Cash (Q1, 2026)
- ¥296.1M
- EBIT (Q1, 2026)
- ¥33.8M
- Enterprise value
- $5.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026